GGrantIndex
← Leaderboards

Vahram Haroutunian

Icahn School Of Medicine At Mount Sinai

$39,970,462
Attributed
$101,707,023
Total exposure
25
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $14.1M · FY200525
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$116,876,297 · 23
VA$0 · 3

By mechanism

R01$44,357,292 · 6
U01$37,032,325 · 4
P01$16,164,881 · 3
N01$8,836,173 · 2
P50$5,938,547 · 6
RF1$3,514,658 · 1

Top collaborators

Most similar at Icahn School Of Medicine At Mount Sinai

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposBrainBrain TissueAutopsyS DiseaseData SetTissuesGenesCellsGene ExpressionMolecularCommunitiesCell TypeBaseNeuronsSamplingSpecimenBrain RegionAffectFuturePhenotypePathway InteractionsNeuropathologySchizophrenia

Grant awards (150)

The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease$2,144,415
R01 · FY2025 · AG
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,242,150
R01 · FY2025 · AG
NIH BRAIN AND TISSUE RESPOSITORY (NBTR)$221,987
N01 · FY2025 · DA · contact PI
The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease$2,188,178
R01 · FY2024 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$1,513,570
R01 · FY2024 · AG
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,267,500
R01 · FY2024 · AG
The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease$2,438,178
R01 · FY2023 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$1,935,901
R01 · FY2023 · AG
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$1,833,218
R01 · FY2023 · AG
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,267,500
R01 · FY2023 · AG
Functional genomic resource and integrative model of dopaminergic circuitry associated with psychiatric disease$660,307
U01 · FY2023 · DA
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$421,204
R01 · FY2023 · AG
Neuropathology Core$275,302
P30 · FY2023 · AG · contact PI
NIH BRAIN AND TISSUE RESPOSITORY (NBTR)$75,000
N01 · FY2023 · DA · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$2,272,422
U01 · FY2022 · AG
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$1,833,217
R01 · FY2022 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$1,513,570
R01 · FY2022 · AG
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE$1,438,562
N01 · FY2022 · DA · contact PI
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,267,500
R01 · FY2022 · AG
The 3D genome in transcriptional regulation across the postnatal life span, with implications for schizophrenia and bipolar disorder$1,172,284
U01 · FY2022 · MH
Functional genomic resource and integrative model of dopaminergic circuitry associated with psychiatric disease$660,307
U01 · FY2022 · DA
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$441,355
R01 · FY2022 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$422,331
R01 · FY2022 · AG
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$422,046
R01 · FY2022 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$250,000
R01 · FY2022 · AG
Neuropathology Core$242,495
P30 · FY2022 · AG · contact PI
Single-nucleus transcriptome profiling across multiple brain regions in Parkinson's Disease$2,099,553
U01 · FY2021 · NS
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,848,040
U01 · FY2021 · AG
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$1,831,622
R01 · FY2021 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$1,513,570
R01 · FY2021 · AG
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE$1,347,260
N01 · FY2021 · DA · contact PI
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,268,438
R01 · FY2021 · AG
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease$1,211,963
R01 · FY2021 · AG
The 3D genome in transcriptional regulation across the postnatal life span, with implications for schizophrenia and bipolar disorder$1,163,690
U01 · FY2021 · MH
Functional genomic resource and integrative model of dopaminergic circuitry associated with psychiatric disease$722,242
U01 · FY2021 · DA
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$338,022
R01 · FY2021 · AG
Neuropathology Core$272,129
P30 · FY2021 · AG · contact PI
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$253,798
R01 · FY2021 · AG
Identification and characterization of receptors targeting VGF-derived peptides.$169,500
U01 · FY2021 · AG
Functional genomic resource and integrative model of dopaminergic circuitry associated with psychiatric disease$14,740
U01 · FY2021 · DA
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$3,115,604
U01 · FY2020 · AG
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$1,875,015
R01 · FY2020 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$1,530,945
R01 · FY2020 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,265,373
U01 · FY2020 · AG
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease$1,224,616
R01 · FY2020 · AG
The 3D genome in transcriptional regulation across the postnatal life span, with implications for schizophrenia and bipolar disorder$1,173,570
U01 · FY2020 · MH
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$847,139
R01 · FY2020 · AG
Functional genomic resource and integrative model of dopaminergic circuitry associated with psychiatric disease$722,242
U01 · FY2020 · DA
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE$555,149
N01 · FY2020 · DA · contact PI
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$436,643
R01 · FY2020 · AG
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE$328,123
N01 · FY2020 · DA · contact PI
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$250,000
R01 · FY2020 · AG
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$249,276
R01 · FY2020 · AG
Neuropathology Core$242,495
P30 · FY2020 · AG · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$164,076
U01 · FY2020 · AG
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease$1,925,544
R01 · FY2019 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,691,295
U01 · FY2019 · AG
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease$1,248,971
R01 · FY2019 · AG
The 3D genome in transcriptional regulation across the postnatal life span, with implications for schizophrenia and bipolar disorder$1,161,648
U01 · FY2019 · MH
Functional genomic resource and integrative model of dopaminergic circuitry associated with psychiatric disease$722,242
U01 · FY2019 · DA
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE$500,000
N01 · FY2019 · DA · contact PI
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE$500,000
N01 · FY2019 · DA · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$423,750
U01 · FY2019 · AG
Core D - Neuropathology$218,381
P50 · FY2019 · AG · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,708,836
U01 · FY2018 · AG
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease$1,263,645
R01 · FY2018 · AG
The 3D genome in transcriptional regulation across the postnatal life span, with implications for schizophrenia and bipolar disorder$1,224,578
U01 · FY2018 · MH
NIMH, NICHD, AND NINDS BRAIN AND TISSUE REPOSITORY$524,312
N01 · FY2018 · MH · contact PI
Core D - Neuropathology$209,372
P50 · FY2018 · AG · contact PI
IGF::OT::IGF$174,771
N01 · FY2018 · MH · contact PI
Neurobiological mechanisms of reduced AD-neuropathology by treatment of diabetes$0
I01 · FY2018 · VA · contact PI
ShEEP Request for fluorescence activated cell sorter (FACS; MoFlo Astrios EQ)$0
IS1 · FY2018 · VA · contact PI
Towards a comprehensive signaling pathway map of parahippocampal vulnerability in Alzheimers Disease$3,514,658
RF1 · FY2017 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$2,699,009
U01 · FY2017 · AG
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease$1,322,834
R01 · FY2017 · AG
NIMH, NICHD, AND NINDS BRAIN AND TISSUE REPOSITORY$802,879
N01 · FY2017 · MH · contact PI
Core D - Neuropathology$189,166
P50 · FY2017 · AG · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$169,498
U01 · FY2017 · AG
Neurobiological mechanisms of reduced AD-neuropathology by treatment of diabetes$0
I01 · FY2017 · VA · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$3,281,179
U01 · FY2016 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,139,520
U01 · FY2016 · AG
NIMH, NICHD, AND NINDS BRAIN AND TISSUE REPOSITORY$614,755
N01 · FY2016 · MH · contact PI
Core D - Neuropathology$187,644
P50 · FY2016 · AG · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$168,108
U01 · FY2016 · AG
IGF::OT::IGF$164,738
N01 · FY2016 · MH · contact PI
Neurobiological mechanisms of reduced AD-neuropathology by treatment of diabetes$0
I01 · FY2016 · VA · contact PI
ShEEP Grant Application: Digital Histology and Microscopy for Human and Animal Tissue$0
IS1 · FY2016 · VA · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,702,824
U01 · FY2015 · AG
NIMH, NICHD, AND NINDS BRAIN AND TISSUE REPOSITORY$479,823
N01 · FY2015 · MH · contact PI
Core D - Neuropathology$189,163
P50 · FY2015 · AG · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$111,000
U01 · FY2015 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$96,335
U01 · FY2015 · AG
Neurobiological mechanisms of reduced AD-neuropathology by treatment of diabetes$0
I01 · FY2015 · VA · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,734,746
U01 · FY2014 · AG
NIMH, NICHD, AND NINDS BRAIN AND TISSUE REPOSITORY$621,127
N01 · FY2014 · MH · contact PI
Accelerating Medicine Partnership in Alzheimer's Disease: Enabling collaborative$114,059
U01 · FY2014 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,659,748
U01 · FY2013 · AG
NIMH, NICHD, AND NINDS BRAIN AND TISSUE REPOSITORY$487,687
N01 · FY2013 · MH · contact PI
Contribution of cell cycle processes to myelin deficits in schizophrenia$280,665
R01 · FY2012 · MH · contact PI
P5-Mouse Phenotyping$74,421
P50 · FY2012 · MH · contact PI
Core B-Clinical/Brain Bank Core$74,420
P50 · FY2012 · MH · contact PI
Core C-Data Management and Statistics$74,420
P50 · FY2012 · MH · contact PI
Core B-Clinical/Brain Bank Core$392,090
P50 · FY2011 · MH · contact PI
Contribution of cell cycle processes to myelin deficits in schizophrenia$280,665
R01 · FY2011 · MH · contact PI
P5-Mouse Phenotyping$230,182
P50 · FY2011 · MH · contact PI
Core C-Data Management and Statistics$207,291
P50 · FY2011 · MH · contact PI
Contribution of cell cycle processes to myelin deficits in schizophrenia$37,800
R01 · FY2011 · MH · contact PI
Core B-Clinical/Brain Bank Core$396,051
P50 · FY2010 · MH · contact PI
Contribution of cell cycle processes to myelin deficits in schizophrenia$283,500
R01 · FY2010 · MH · contact PI
P5-Mouse Phenotyping$232,507
P50 · FY2010 · MH · contact PI
Core C-Data Management and Statistics$209,386
P50 · FY2010 · MH · contact PI
Contribution of Cell Cycle Processes to Myelin Deficits in Schizophrenia$478,858
R01 · FY2009 · MH · contact PI
Core B-Clinical/Brain Bank Core$401,367
P50 · FY2009 · MH · contact PI
Clinical and Biological Studies of Early AD$400,000
P01 · FY2009 · AG · contact PI
Contribution of cell cycle processes to myelin deficits in schizophrenia$283,500
R01 · FY2009 · MH · contact PI
P5-Mouse Phenotyping$234,835
P50 · FY2009 · MH · contact PI
Core C-Data Management and Statistics$211,989
P50 · FY2009 · MH · contact PI
CORE--DATA MANAGEMENT$122,842
P50 · FY2009 · AG · contact PI
Clinical and Biological Studies of Early AD$2,036,963
P01 · FY2008 · AG · contact PI
Core B-Clinical/Brain Bank Core$400,673
P50 · FY2008 · MH · contact PI
Contribution of cell cycle processes to myelin deficits in schizophrenia$283,500
R01 · FY2008 · MH · contact PI
P5-Mouse Phenotyping$233,644
P50 · FY2008 · MH · contact PI
Core C-Data Management and Statistics$211,415
P50 · FY2008 · MH · contact PI
DATA MANAGEMENT AND STATISTICS CORE$176,197
P01 · FY2008 · AG · contact PI
CORE--DATA MANAGEMENT$119,558
P50 · FY2008 · AG · contact PI
Clinical and Biological Studies of Early AD$2,065,348
P01 · FY2007 · AG · contact PI
Core B-Clinical/Brain Bank Core$411,933
P50 · FY2007 · MH · contact PI
Cortico-thalamic Glutamate/GABA mRNA in schizophrenia$276,277
R01 · FY2007 · MH · contact PI
P5-Mouse Phenotyping$239,423
P50 · FY2007 · MH · contact PI
Core C-Data Management and Statistics$220,150
P50 · FY2007 · MH · contact PI
DATA MANAGEMENT AND STATISTICS CORE$179,206
P01 · FY2007 · AG · contact PI
CORE--DATA MANAGEMENT$118,730
P50 · FY2007 · AG · contact PI
Clinical and Biological Studies of Early AD$2,116,928
P01 · FY2006 · AG · contact PI
Cortico-thalamic Glutamate/GABA mRNA in schizophrenia$284,528
R01 · FY2006 · MH · contact PI
DATA MANAGEMENT AND STATISTICS CORE$158,615
P01 · FY2006 · AG · contact PI
CORE--DATA MANAGEMENT$64,688
P50 · FY2006 · AG · contact PI
Clinical and Biological Studies of Early AD$2,154,672
P01 · FY2005 · AG
Cortico-thalamic Glutamate/GABA mRNA in schizophrenia$291,375
R01 · FY2005 · MH
DATA MANAGEMENT AND STATISTICS CORE$158,043
P01 · FY2005 · AG
CORE--DATA MANAGEMENT$62,806
P50 · FY2005 · AG
Clinical and Biological Studies of Early AD$2,146,611
P01 · FY2004 · AG
Cortico-thalamic Glutamate/GABA mRNA in schizophrenia$291,375
R01 · FY2004 · MH
ADMINISTRATIVE CORE$164,454
P01 · FY2004 · AG
CLIN AND BIOLOGIC STUDIES OF EARLY ALZHEIMERS DISEASE$161,471
P01 · FY2004 · AG
DATA MANAGEMENT AND STATISTICS CORE$159,092
P01 · FY2004 · AG
CLIN AND BIOLOGIC STUDIES OF EARLY ALZHEIMERS DISEASE$2,200,067
P01 · FY2003 · AG
Cortico-thalamic Glutamate/GABA mRNA in schizophrenia$291,375
R01 · FY2003 · MH
CLIN AND BIOLOGIC STUDIES OF EARLY ALZHEIMERS DISEASE$1,887,214
P01 · FY2002 · AG
Core--Data Management and Statistics$0
P50 · FY2002 · MH
Core--Brain Bank$0
P50 · FY2002 · MH